TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

CLINDAMYCIN PHOSPHATE AND TRETINOIN

CLINDAMYCIN PHOSPHATE
Infectious Disease Approved 2015-06-12
3
Indications
--
Phase 3 Trials
10
Years on Market

Details

Status
Prescription
First Approved
2015-06-12
Routes
TOPICAL
Dosage Forms
GEL

CLINDAMYCIN PHOSPHATE AND TRETINOIN Approval History

Loading approval history...

What CLINDAMYCIN PHOSPHATE AND TRETINOIN Treats

1 indications

CLINDAMYCIN PHOSPHATE AND TRETINOIN is approved for 1 conditions since its original approval in 2015. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Acne Vulgaris
Source: FDA Label

Drugs Similar to CLINDAMYCIN PHOSPHATE AND TRETINOIN

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ACANYA
BENZOYL PEROXIDE
1 shared
BAUSCH
Shared indications:
Acne Vulgaris
ACZONE
DAPSONE
1 shared
ALMIRALL
Shared indications:
Acne Vulgaris
ADAPALENE AND BENZOYL PEROXIDE
ADAPALENE
1 shared
PADAGIS ISRAEL
Shared indications:
Acne Vulgaris
AKLIEF
TRIFAROTENE
1 shared
GALDERMA LABS LP
Shared indications:
Acne Vulgaris
ALTRENO
TRETINOIN
1 shared
DOW PHARM
Shared indications:
Acne Vulgaris
AMZEEQ
MINOCYCLINE HYDROCHLORIDE
1 shared
JOURNEY
Shared indications:
Acne Vulgaris
ARAZLO
TAZAROTENE
1 shared
BAUSCH
Shared indications:
Acne Vulgaris
ATRALIN
TRETINOIN
1 shared
DOW PHARM
Shared indications:
Acne Vulgaris
AVAGE
TAZAROTENE
1 shared
ALMIRALL
Shared indications:
Acne Vulgaris
AZELEX
AZELAIC ACID
1 shared
ALMIRALL
Shared indications:
Acne Vulgaris
BENZAMYCIN
BENZOYL PEROXIDE
1 shared
VALEANT INTL
Shared indications:
Acne Vulgaris
CABTREO
ADAPALENE
1 shared
BAUSCH
Shared indications:
Acne Vulgaris
CLEOCIN T
CLINDAMYCIN PHOSPHATE
1 shared
Pfizer
Shared indications:
Acne Vulgaris
CLINDA-DERM
CLINDAMYCIN PHOSPHATE
1 shared
PADAGIS US
Shared indications:
Acne Vulgaris
CLINDAGEL
CLINDAMYCIN PHOSPHATE
1 shared
BAUSCH
Shared indications:
Acne Vulgaris
CLINDAMYCIN PHOSPHATE
CLINDAMYCIN PHOSPHATE
1 shared
TARO
Shared indications:
Acne Vulgaris
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
BENZOYL PEROXIDE
1 shared
Teva
Shared indications:
Acne Vulgaris
CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE
CLINDAMYCIN PHOSPHATE
1 shared
Baxter
Shared indications:
Acne Vulgaris
CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER
CLINDAMYCIN PHOSPHATE
1 shared
RISING
Shared indications:
Acne Vulgaris
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
CLINDAMYCIN PHOSPHATE
1 shared
ABRAXIS PHARM
Shared indications:
Acne Vulgaris
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CLINDAMYCIN PHOSPHATE AND TRETINOIN FDA Label Details

Pro

Indications & Usage

Clindamycin phosphate and tretinoin gel 1.2% / 0.025% is indicated for the topical treatment of acne vulgaris in patients 12 years or older. Clindamycin phosphate and tretinoin gel 1.2% / 0.025% is a lincosamide antibiotic and retinoid combination product indicated for the topical treatment of acne vulgaris in patients 12 years or older.

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.